Celltrion, Inc. (KRX:068270)

Celltrion Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	4,465,569	4,162,495	3,557,304	2,176,432	2,283,967	1,893,401
Revenue Growth	21.94%	17.01%	63.45%	-4.71%	20.63%	2.40%
Gross Profit Gross Profit Growth	2,709,998	2,467,027	1,681,713	1,051,869	1,032,697	1,087,594
Operating Income Operating Income Growth	1,336,995	1,164,546	492,016	651,434	647,200	744,163
Net Income Net Income Growth	1,267,092	1,029,613	422,692	535,648	537,836	579,465
Earnings Per Share EPS Growth	5485.59	4438.10	1786.67	3273.16	3258.27	3472.89
EPS Growth	154.17%	148.40%	-45.41%	0.46%	-6.18%	13.28%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Biopharmaceutical Medicines Biopharmaceutical Medicines Growth	6,033,277	6,033,277	6,070,131	1,873,430	1,937,469	1,615,840
Chemical Medicines Chemical Medicines Growth	556,710	556,710	531,389	500,777	653,519	538,511
Other Segments Other Segments Growth	6,737	6,737	5,825	5,143	3,877	3,054
Adjustments Adjustments Growth	-2,434,229	-2,434,229	-3,050,041	-202,919	-310,898	-264,004

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	1,418,676	1,239,107	1,143,046	757,497	594,464	1,219,901
Total Debt Total Debt Growth	3,866,065	3,729,110	2,192,676	1,890,420	792,332	744,356
Net Cash (Debt) Net Cash Growth	-2,447,389	-2,490,004	-1,049,630	-1,132,923	-197,868	475,545
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-10593.19	-10732.04	-4437.60	-6922.91	-1198.75	2849.69

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	770,757	646,051	901,870	537,159	863.53	911,159
Capital Expenditures CapEx Growth	-114,237	-108,224	-135,059	-210,046	-111,169	-63,379
Free Cash Flow Free Cash Flow Growth	656,520	537,827	766,812	327,112	-110,305	847,780
Free Cash Flow Growth	-23.07%	-29.86%	134.42%	-	-	221.45%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	60.69%	59.27%	47.27%	48.33%	45.21%	57.44%
Operating Margin	29.94%	27.98%	13.83%	29.93%	28.34%	39.30%
Pretax Margin	31.14%	27.72%	16.20%	30.83%	27.42%	39.01%
Profit Margin	28.38%	24.73%	11.88%	24.61%	23.55%	30.60%
FCF Margin	14.70%	12.92%	21.56%	15.03%	-4.83%	44.78%

Dividends

Chart

Fiscal Year	Current	FY 2025
Period Ending	Aug 10, 2026	Dec 31, 2025
Dividend Per Share Dividend Per Share Growth	714.286	714.286
Dividend Per Share Growth	4.00%	-
Dividend Yield	0.36%	0.41%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	36.33	38.46	95.50	52.22	42.77	47.62
Forward PE	32.43	40.41	48.86	76.81	41.12	52.71
P/FCF Ratio	69.62	73.63	52.64	85.51	-	32.55
PS Ratio	10.23	9.51	11.35	12.85	10.07	14.57

Data Sources: S&P Global Market Intelligence and Fiscal.ai Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company. Revenue segment data is provided by Fiscal.ai.

Update frequency:

Quarterly

Last checked:

Aug 9, 2026

Data Sources Report a data error